维普中文期刊产品整合服务
76篇 您的检索式:作者名="Teede HJ"
    题名 作者 年代 出处 被引量
1Insulin-sensitisers in the treatment of polycystic ovary syndrome显示文摘TEEDE HJ MEYER C NORMAN RJ 2005Expert Opin Pharmacother2005,6,:1
2Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation 显示文摘Deeks AA Gibson - Helm ME Teede HJ 2010Fertil Steril2010,93,7:1
3Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome显示文摘Moran LJ Teede HJ Noakes M 2013J Endocrinol Invest2013,36,11:1
4Understanding health behaviours in a cohort of pregnant women at risk of gestational diabetes mellitus: an observational study显示文摘Harrison CL Lombard CB Teede HJ 2012BJOG2012,119,6:1
5Assessment and manage- ment of polycystic ovary syndrome: summary of an evidence - based guideline 显示文摘Teede HJ Misso ML Deeks AA 2011Med J Aust2011,195,6:1
6Endothelial function and insulin resistance in polycystic ova syndrome: the effects of medical therapy显示文摘Teede HJ Meyer C Hutchison SK 2010Fertil Steril2010,93,1:1
7The management of insulin resistance in polycystic ovary syndrome显示文摘Teede HJ Hutchison SK Zoungas S 2007Trends Endocrinol Metab2007,18,7:1
8Assessment and management of polycystic ovary syndrome:summary of an evidence-based guideline 显示文摘Teede HJ Misso ML Deeks AA 2011Med J Aust2011,195,6:1
9Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease 显示文摘Meyer C McGrath BP Teede HJ 2005Clin Endocrinol Metab2005,90,10:1
10Aromatase inhibitors for pcas: a systematic review and meta-analysis显示文摘Misso ML Wong JL Teede HJ 2012Hum Reprod Update2012,18,3:1
11Treatment of obesity in polycystic ovary syndrome:a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society 显示文摘Moran I l Pasquali R Teede HJ 2009Fertil Steril2009,92,6:1
12Polycystic ovary syndrome and anti-Müllerian hormone:role of insulin resistance,androgens,obesity and gonadotrophins显示文摘Cassar S Teede HJ Moran LJ 2014Clin Endocrinol(Oxf)2014,81,:1
13Treatment of obesity in polyeystic ovary syndrome:a position statement of the Andro- gen excess and po|ycystic ovary syndrome society 显示文摘Moran LJ Pasquali R Teede HJ 2009Fertil Steril2009,92,6:1
14Sex hormones and the cardiovascular system: effects on arterial function in women显示文摘Teede HJ 2007Clin Exp Pharmacol Physiol2007,34,7:1
15Treatment of obesity in polycystic ovary syndrome:a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society显示文摘Moran LJ Pasquali R Teede HJ 2009Fertil Steril2009,92,6:1
16The management of insulin resistance in polycystie ovary syndrome显示文摘Teede HJ Hutchison SK Zoungas S 2007Trends in En- docrinology and Metabolism2007,18,7:1
17Assessment and management of polyeystie ovary syndrome : summary of an evidence-based guideline 显示文摘Teede HJ Misso ML Deeks AA 2011Med J Aust2011,195,6:1
18Sex hormones and the cardiovascular system: effects on arterial function in women显示文摘Teede HJ 2007Clin Exp Pharmacol Physiol2007,34,7:1
19Aromatase inhibitors for PCOS:a systematic review and meta-analysis 显示文摘Misso ML Wong JL Teede HJ 2012Hum Reprod Update2012,18,3:1
20Polycystic ovary syndrome and anti-Müllerian hormone:role of insulin resistance,androgens,obesity and gonadotrophins显示文摘Cassar S Teede HJ Moran LJ 2014Clin Endocrinol(Oxf)2014,81,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费